Muscle function in COPD: a complex interplay
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The skeletal muscles play an essential role in life, providing the mechanical basis for respiration and movement. Skeletal muscle dysfunction is prevalent in all stages of chronic obstructive pulmonary disease (COPD), and significantly influences symptoms, functional capacity, health related quality of life, health resource usage and even mortality. Furthermore, in contrast to the lungs, the skeletal muscles are potentially remedial with existing therapy, namely exercise-training. This review summarizes clinical and laboratory observations of the respiratory and peripheral skeletal muscles (in particular the diaphragm and quadriceps), and current understanding of the underlying etiological processes. As further progress is made in the elucidation of the molecular mechanisms of skeletal muscle dysfunction, new pharmacological therapies are likely to emerge to treat this important extra-pulmonary manifestation of COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 2×
“Another downstream regulator of anabolism, which is mTOR independent, is the phosphorylation of glycogen synthase kinase-3β (GSK-3β) by phosphorylated Akt.(95) This leads to the release of eukaryotic initiation factor 2B (eIF2B) which upregulates MPS.”
BackgroundRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 1×
“The muscle-specific ubiquitin ligases contribute to protein degradation via the ubiquitinproteasome pathway.(97)”
BackgroundSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“It downregulates two muscle-specific E3 ligases, atrogin-1 (muscle atrophy F-box or MAFbx), and muscle-specific RING finger protein (MuRF)-1 via inactivation of the forkhead box class O (FoxO) family of transcription factors.(96) The muscle-specific ubiquitin ligases contribute to protein degradation via the ubiquitin…”
BackgroundPulmonary rehabilitation for chronic obstructive pulmonary disease
McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., & Lacasse, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003793.pub3 · Cited by 2,643
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease
Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-855oc · Cited by 1,256 · cited 1×
“With advancing airway obstruction severity, physical activity declines and matches the loss of muscle mass observed in COPD patients,(54) which correlates with muscle force.(55) Abnormalities in the quadriceps muscle in COPD patients are similarly observed in patients with other chronic diseases, such as heart failure…”
BackgroundAMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Griffiths, T., Burr, M., Campbell, I., Lewis-Jenkins, V, Mullins, J., Shiels, K., Turner-Lawlor, P., Payne, N., Newcombe, R., Lonescu, A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07042-7 · Cited by 952
Pulmonary rehabilitation for chronic obstructive pulmonary disease
Lacasse, Y., Goldstein, R., Lasserson, T. J., & Martin, S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003793.pub2 · Cited by 821
Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease
BERNARD, S., LeBLANC, P., WHITTOM, F., CARRIER, G., JOBIN, J., BELLEAU, R., & MALTAIS, F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9711023 · Cited by 817
Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D.-C., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J., & Polkey, M. I. (2007) · Thorax · doi:10.1136/thx.2006.062026 · Cited by 728 · cited 1×
“Skeletal muscle dysfunction is of particular interest, as it directly influences exercise performance,(3) is associated with poor health status,(4) and is an independent predictor of health care utilization(5) and mortality.(6) Furthermore, respiratory muscle function plays a key role in the pathogenesis of breathless…”
BackgroundSelf-citationO'DONNELL, D. E., LAM, M., & WEBB, K. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804004 · Cited by 532 · cited 1×
“As expiratory flow limitation is commonly present in COPD, increased ventilation can exacerbate dynamic hyperinflation and promote premature exercise termination and dyspnea.(140) Quadriceps strength, endurance, and fatigability all improve significantly following exercise training.”
BackgroundImpact of inspiratory muscle training in patients with COPD: what is the evidence?
Gosselink, R., De Vos, J., van den Heuvel, S. P., Segers, J., Decramer, M., & Kwakkel, G. (2011) · European Respiratory Journal · doi:10.1183/09031936.00031810 · Cited by 524
Peroxisome proliferator‐activated receptor δ controls muscle development and oxydative capability
Luquet, S., Lopez‐Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., & Grimaldi, P. A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0269fje · Cited by 509
Contractile Properties of the Human Diaphragm during Chronic Hyperinflation
Similowski, T., Yan, S., Gauthier, A. P., Macklem, P. T., & Bellemare, F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251304 · Cited by 473 · cited 1×
“Indeed, when corrected for lung volume, the contractile strength of the diaphragm in COPD is not reduced compared with controls(11) and may even be enhanced in some cases.(31) The maintenance of strength in this muscle is probably due to persistent involuntary training secondary to the increased work of breathing.”
BackgroundPulmonary Rehabilitation for Management of Chronic Obstructive Pulmonary Disease
Casaburi, R., & ZuWallack, R. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0804632 · Cited by 270
Sumukadas, D., Witham, M. D., Struthers, A. D., & McMurdo, M. E. T. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061339 · Cited by 246 · cited 1×
“Certainly, this approach has been used with positive results in elderly people with functional impairment.(162) Similarly, levosimendan, a calcium sensitizer used as a cardiac inotrope, has recently been shown to improve neuro-mechanical efficiency and contractile function of the human diaphragm in healthy subjects,(1…”
BackgroundMuscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Doucet, M., Russell, A. P., Léger, B., Debigaré, R., Joanisse, D. R., Caron, M.-A., LeBlanc, P., & Maltais, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-704oc · Cited by 243 · cited 1×
“group consistent with previous reports of the overexpression of muscle hypertrophy pathways.(98) MiR-1 may also”
ResultChronic Obstructive Pulmonary Disease: Capillarity and Fiber-Type Characteristics of Skeletal Muscle
Jobin, J., Maltais, F., Doyon, J.-F., LeBlanc, P., Simard, P.-M., Simard, A.-A., & Simard, C. (1998) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199811000-00005 · Cited by 224
Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease
Orozco-Levi, M., Gea, J., Lloreta, J., Felez, M., Minguella, J., Serrano, S., & Broquetas, J. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13237199 · Cited by 203
Gosker, H. R., Engelen, M. P., van Mameren, H., van Dijk, P. J., van der Vusse, G. J., Wouters, E. F., & Schols, A. M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.113 · Cited by 200
Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease
Plant, P. J., Brooks, D., Faughnan, M., Bayley, T., Bain, J., Singer, L., Correa, J., Pearce, D., Binnie, M., & Batt, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0382oc · Cited by 190 · cited 1×
“Myostatin mRNA was elevated in weak COPD patients.(99) Following an in-patient resistance training program, hospitalized COPD patients had reduced myostatin transcripts, with a trend toward an increase in MyoD and myogenin.”
BackgroundCytokine Profile in Quadriceps Muscles of Patients with Severe COPD
Barreiro, E., Schols, A. M. W. J., Polkey, M. I., Galdiz, J. B., Gosker, H. R., Swallow, E. B., Coronell, C., Gea, J., & on behalf of the ENIGMA in COPD project (2007) · Thorax · doi:10.1136/thx.2007.078030 · Cited by 175
Self-citationPeroxisome Proliferator-Activated Receptor Expression Is Reduced in Skeletal Muscle in COPD
Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., & Schols, A. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00144106 · Cited by 168
Palange, P., Valli, G., Onorati, P., Antonucci, R., Paoletti, P., Rosato, A., Manfredi, F., & Serra, P. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01207.2003 · Cited by 162
Downregulation of the Serum Response Factor/MiR-1 Axis in the Quadriceps of Patients with COPD
Lewis, A., Riddoch-Contreras, J., Natanek, S. A., Donaldson, A., Man, W. D.-C., Moxham, J., Hopkinson, N. S., Polkey, M. I., & Kemp, P. R. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200309 · Cited by 156
Self-citationChronic Endurance Exercise Induces Quadriceps Nitrosative Stress in Patients with Severe COPD
Barreiro, E., Rabinovich, R., Marin-Corral, J., Barbera, J. A., Gea, J., & Roca, J. (2008) · Thorax · doi:10.1136/thx.2008.105163 · Cited by 133
Crul, T., Spruit, M. A., Gayan‐Ramirez, G., Quarck, R., Gosselink, R., Troosters, T., Pitta, F., & Decramer, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01867.x · Cited by 117
Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Petersen, A. M. W., Penkowa, M., Iversen, M., Frydelund-Larsen, L., Andersen, J. L., Mortensen, J., Lange, P., & Pedersen, B. K. (2007) · Lung · doi:10.1007/s00408-007-9000-7 · Cited by 83
MAPK Signaling in the Quadriceps of Patients with Chronic Obstructive Pulmonary Disease
Lemire, B. B., Debigaré, R., Dubé, A., Thériault, M.-E., Côté, C. H., & Maltais, F. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01518.2011 · Cited by 51
Quadriceps Myostatin Expression in COPD
D-C. Man, W., Natanek, S. A., Riddoch-Contreras, J., Lewis, A., Marsh, G. S., Kemp, P. R., & Polkey, M. I. (2010) · European Respiratory Journal · doi:10.1183/09031936.00032510 · Cited by 48 · cited 1×
“Our group have also demonstrated a negative association between quadriceps muscle myostatin mRNA expression and quadriceps muscle strength in COPD patients.(112) Animal studies have shown that skeletal muscle-fiber phenotype appears to be regulated by several independent signaling pathways.”
BackgroundSelf-citationRiddoch-Contreras, J., George, T., Natanek, S. A., Marsh, G. S., Hopkinson, N. S., Tal-Singer, R., Kemp, P., & Polkey, M. I. (2012) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.644359 · Cited by 17
Self-citation
Cited by
Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation
Jones, S. E., Maddocks, M., Kon, S. S. C., Canavan, J. L., Nolan, C. M., Clark, A. L., Polkey, M. I., & Man, W. D.-C. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206440 · Cited by 435
Self-citationPhysical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
Maddocks, M., Kon, S. S. C., Canavan, J. L., Jones, S. E., Nolan, C. M., Labey, A., Polkey, M. I., & Man, W. D.-C. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208460 · Cited by 314
Self-citationSarcopenia and frailty in chronic respiratory disease: Lessons from gerontology
Bone, A. E., Hepgul, N., Kon, S., & Maddocks, M. (2017) · Chronic Respiratory Disease · doi:10.1177/1479972316679664 · Cited by 309
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
Jones, S., Man, W. D.-C., Gao, W., Higginson, I. J., Wilcock, A., & Maddocks, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009419.pub3 · Cited by 292
Self-citationCardim, A. B., Marinho, P. E., Nascimento, J. F., Fuzari, H. K., & Dornelas de Andrade, A. (2016) · Respiratory Care · doi:10.4187/respcare.04763 · Cited by 32
Metadata
- Authors
- Man, W., Donaldson, Maddocks, Martolini, & Polkey, M.
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2012-08
- Volume
- 7
- Pages
- 523
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- OpenAlex
- W2100476377
- Cited by
- 147
- References
- 40
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.